A new pancreatic cancer vaccine produced lasting immune responses, raising hopes of stopping the disease before it starts.

Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and ...

The study conducted on how tumours manipulate the thymus helps scientists enhance the effectiveness of cancer immunotherapy ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat ...

An ancient molecule that existed long before the circulatory system evolved has been found to support cancer immunotherapy.

Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...

Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...

A new vaccine trial conducted on humans for pancreatic cancer, one of the deadliest malignancies in the world, showed immense ...

Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune ...

Researchers have discovered a way to make the immune system's T cells significantly more effective at fighting cancer. By blocking a protein called Ant2, they were able to reprogram how these cells ...

Researchers have found that a yeast-derived dietary supplement can reprogram developing immune cells in obese mice, ...